OncologyMAP v. 3.0 is a powerful research tool developed with funding and direction from the National Cancer Institute and the Cancer Prevention Research Institute of Texas *. It is a comprehensive, cost-effective testing service that quantitatively measures more than 130 cancer-related proteins which can help researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring.
1 This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only.
2 This assay did not meet performance specifications in Serum and results should be used for information purposes only.
Intended for Research Use Only.
|Serum or plasma||Other fluids*|
|500 µL||2 mL|